Foghorn Therapeutics (FHTX) Interest Expenses (2019 - 2021)

Foghorn Therapeutics' Interest Expenses history runs 3 years deep, the most recent figure standing at $426000.0 for Q4 2021.

• In Q4 2021, Interest Expenses rose 32.71% year-over-year to $426000.0; the TTM figure through Sep 2022 stood at $426000.0 (down 76.35% YoY), while the FY2021 annual figure was $1.9 million, up 94.69% from the prior year.
• Interest Expenses was $426000.0 for Q4 2021 at Foghorn Therapeutics, down from $499000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $499000.0 in Q3 2021 to a low of $113000.0 in Q3 2019.
• Historically, Interest Expenses has averaged $317600.0 across 3 years, with a median of $289500.0 in 2020.
• Biggest YoY gain for Interest Expenses was 150.0% in 2021; the steepest drop was 32.71% in 2021.
• A 3-year view of Interest Expenses shows it stood at $178000.0 in 2019, then soared by 80.34% to $321000.0 in 2020, then soared by 32.71% to $426000.0 in 2021.
• The last three Interest Expenses figures came in at $426000.0 (Q4 2021), $499000.0 (Q3 2021), and $495000.0 (Q2 2021), per Business Quant data.